Table 1.
Study Characteristics of 105 Studies
| Variables | N or Median | % or Q1–Q3 (range) |
|---|---|---|
| Sample size (n) | 119 | 62–29 (14–7321) |
| Randomized trial | 26 | 25% |
| Intervention‐baseda | 37 | 35% |
| Multicenter study | 24 | 23% |
| Follow‐up duration (d) | 91 | 42–182 (4–1825) |
| Number of follow‐ups | ||
| 1 | 7 | 7% |
| 2 | 27 | 26% |
| 3 | 35 | 33% |
| 4 | 21 | 20% |
| 5 | 7 | 7% |
| 6–9 | 8 | 8% |
| Domains | ||
| Nociceptive symptoms | 60 | 57% |
| Activities of daily living | 51 | 49% |
| Cognitive | 18 | 17% |
| Mental health | 58 | 55% |
| Physical function | 55 | 52% |
| Sleep | 11 | 10% |
| Number of domains assessed | ||
| 1 | 42 | 40% |
| 2 | 14 | 13% |
| 3 | 17 | 16% |
| 4 | 23 | 22% |
| 5 | 8 | 8% |
| 6 | 0 | 0% |
IQR indicates interquartile range.
a
Intervention‐based refers to studies that examined patient‐reported outcome measures according to different process of care (robotic vs. sternotomy approach, telehealth follow‐up vs. usual care, etc.).